The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.
about
Macular telangiectasia type 2 accompanied by solitary retinal astrocytic hamartoma (case report).Clinical features of idiopathic juxtafoveal telangiectasis in KoreansEfficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal TelangiectasiaMacular telangiectasia type 2.Identification of a potential susceptibility locus for macular telangiectasia type 2.AAV-mediated, optogenetic ablation of Müller Glia leads to structural and functional changes in the mouse retinaAdaptive optics microperimetry and OCT images show preserved function and recovery of cone visibility in macular telangiectasia type 2 retinal lesions.Demographic features of idiopathic macular telangiectasia in Korean patientsSWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF NEOVASCULAR MACULAR TELANGIECTASIA TYPE 2.Treatment of nonneovascular idiopathic macular telangiectasia type 2 with intravitreal ranibizumab: results of a phase II clinical trialUltrastructural and clinical evidence of subretinal debris accumulation in type 2 macular telangiectasia.Prevalence and progression of pigment clumping associated with idiopathic macular telangiectasia type 2.The role of glia in retinal vascular disease.Medical characteristics of patients with macular telangiectasia type 2 (MacTel Type 2) MacTel project report no. 3.CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.
P2860
Q30369195-94065E1F-4B71-42B5-9062-18AD9128E23AQ30474472-4AC4517B-54AD-436B-A285-8EBF641DAE38Q33790472-CFE8DEE2-7ED8-4ED2-935A-F09A076E0595Q34316044-195D87F8-2BAD-4F7A-A416-F5FDBB075568Q34404580-22002569-D93C-44E1-B182-529A8A61DAB4Q35006176-6DBAB74F-919E-43DA-BEA9-FA1C359FEBD9Q35043413-2B74273F-4B6B-4ADA-A5CA-FCEF4A4A7ACCQ35657251-314A59E6-5D1B-4E12-8C1B-7547D8024BE5Q35803256-EA15CD2C-34FF-4704-908A-1C2E6959634AQ36418259-FE61FC51-2AC8-4B5E-9D2B-6D6AD162F7ABQ36440564-6F6A17C7-023B-45F4-873B-75346409D7A8Q36546311-CE5CEC91-6F50-4B6D-BAF5-F473547BAA6EQ38004034-843C7DD7-CAC0-4F2A-8180-82005E451CE3Q39448619-00E06D63-9209-4ADA-B4E8-D8424482D039Q50088688-0BE1CFC5-1671-4E99-AB0D-83554DD2B861
P2860
The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.
@ast
The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.
@en
type
label
The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.
@ast
The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.
@en
prefLabel
The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.
@ast
The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.
@en
P2093
P2860
P1476
The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.
@en
P2093
Barbara A Blodi
Barbara E K Klein
Chelsea E Myers
Stacy M Meuer
P2860
P304
P356
10.1016/J.AJO.2010.02.013
P407
P577
2010-07-01T00:00:00Z